Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 47, 2023 - Issue 3
2,812
Views
2
CrossRef citations to date
0
Altmetric
Review Article

COVID-19 and Anemia: What Do We Know So Far?

, , , , , & ORCID Icon show all
Pages 122-129 | Received 19 Apr 2023, Accepted 05 Jul 2023, Published online: 31 Jul 2023

References

  • Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells. 2021;10(12):3592. doi: 10.3390/cells10123592.
  • Kroll MH, Rojas-Hernandez C, Yee C. Hematologic complications of immune checkpoint inhibitors. Blood. 2022;139(25):3594–3604. doi: 10.1182/blood.2020009016.
  • Fletcher-Sandersjöö A, Bellander BM. Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thromb Res. 2020;194:36–41. doi: 10.1016/j.thromres.2020.06.027.
  • Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. doi: 10.1016/j.jcv.2020.104362.
  • Lanser L, Fuchs D, Kurz K, et al. Physiology and inflammation driven pathophysiology of iron homeostasis-mechanistic insights into anemia of inflammation and its treatment. Nutrients. 2021;13(11):3732. doi: 10.3390/nu13113732.
  • Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40–50. doi: 10.1182/blood-2018-06-856500.
  • Bellmann-Weiler R, Lanser L, Barket R, et al. Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 infection. J Clin Med. 2020;9(8):2429.
  • Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155–162. doi: 10.1097/BOR.0000000000000776.
  • Korompoki E, Gavriatopoulou M, Fotiou D, et al. Late-onset hematological complications post COVID-19: an emerging medical problem for the hematologist. Am J Hematol. 2022;97(1):119–128. doi: 10.1002/ajh.26384.
  • Marchi G, Bozzini C, Bertolone L, et al. Red blood cell morphologic abnormalities in patients hospitalized for COVID-19. Front Physiol. 2022;13:932013. doi: 10.3389/fphys.2022.932013.
  • Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205–1208. doi: 10.1007/s00277-020-04019-0.
  • Gorog DA, Storey RF, Gurbel PA, et al. Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol. 2022;19(7):475–495. doi: 10.1038/s41569-021-00665-7.
  • Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. doi: 10.1007/s00134-020-06062-x.
  • Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002;69(4):258–271. doi: 10.1002/ajh.10062.
  • Maslov DV, Simenson V, Jain S, et al. COVID-19 and cold agglutinin hemolytic anemia. TH Open. 2020;4(3):e175–e177. doi: 10.1055/s-0040-1715791.
  • Russo A, et al. Implication of COVID-19 on erythrocytes functionality: red blood cell biochemical implications and morpho-functional aspects. Int J Mol Sci. 2022;23(4):2171. doi: 10.3390/ijms23042171.
  • Roy NBA, Telfer P, Eleftheriou P, et al. Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID‐19 pandemic. Br J Haematol. 2020;189(4):635–639. doi: 10.1111/bjh.16687.
  • Severance T, Rahim MQ, French J 2nd, et al. COVID-19 and hereditary spherocytosis: a recipe for hemolysis. Pediatr Blood Cancer. 2020;68(1):e28548.
  • Algassim AA, Elghazaly AA, Alnahdi AS, et al. Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection. Ann Hematol. 2021;100(1):37–43. doi: 10.1007/s00277-020-04256-3.
  • Maira D, Duca L, Busti F, et al. The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: the IRONCOVID study. Am J Hematol. 2022;97(11):1404–1412. doi: 10.1002/ajh.26679.
  • Hippchen T, Altamura S, Muckenthaler MU, et al. Hypoferremia is associated with increased hospitalization and oxygen demand in COVID-19 patients. Hemasphere. 2020;4(6):e492. doi: 10.1097/HS9.0000000000000492.
  • Taherifard E, Taherifard E, Movahed H, et al. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases. Hematology. 2021;26(1):225–239. doi: 10.1080/16078454.2021.1881225.
  • Lazarian G, Quinquenel A, Bellal M, et al. Autoimmune haemolytic anaemia associated with COVID‐19 infection. Br J Haematol. 2020;190(1):29–31. doi: 10.1111/bjh.16794.
  • Hernández PV, Rivas YB, Sánchez EO, et al. Autoimmune hemolytic anemia in a pediatric patient with severe acute respiratory syndrome coronavirus 2 infection. Pediatr Infect Dis J. 2020;39(9):e288.
  • Fattizzo B, Pasquale R, Bellani V, et al. Complement mediated hemolytic anemias in the COVID-19 era: case series and review of the literature. Front Immunol. 2021;12:791429. doi: 10.3389/fimmu.2021.791429.
  • Cecchi N, Giannotta JA, Barcellini W, et al. A case of severe aplastic anaemia after SARS-CoV-2 vaccination. Br J Haematol. 2022;196(6):1334–1336. doi: 10.1111/bjh.17947.
  • Fattizzo B, Giannotta JA, Cecchi N, et al. SARS-CoV-2 vaccination in patients with autoimmune cytopenias: the experience of a reference center. Am J Hematol. 2021;96(11):E413–E416.
  • AbouYabis AN, Bell GT. Hemolytic anemia complicating COVID-19 infection. J Hematol. 2021;10(5):221–227. doi: 10.14740/jh906.
  • D’Alessandro A, Thomas T, Dzieciatkowska M, et al. Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level. J Proteome Res. 2020;19(11):4417–4427. doi: 10.1021/acs.jproteome.0c00365.
  • Lam LKM, Reilly JP, Rux AH, et al. Erythrocytes identify complement activation in patients with COVID-19. Am J Physiol Lung Cell Mol Physiol. 2021;321(2):L485–L489. doi: 10.1152/ajplung.00231.2021.
  • Damani J. Disseminated intravascular coagulopathy from warm autoimmune hemolytic anemia in a patient with COVID-19. Chest. 2020;158(4):A397. doi: 10.1016/j.chest.2020.08.388.
  • Grobler C, Maphumulo SC, Grobbelaar LM, et al. Covid-19: the rollercoaster of fibrin(ogen), D-dimer, von Willebrand Factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes. Int J Mol Sci. 2020;21(14):5168. doi: 10.3390/ijms21145168.
  • Solari D, Alberio L, Ribi C, et al. Autoimmune hemolytic anemia and pulmonary embolism: an association to consider. TH Open. 2021;5(1):e8–e13. doi: 10.1055/s-0040-1721733.
  • Patil NR, Herc ES, Girgis M. Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection. Hematol Oncol Stem Cell Ther. 2022;15(4):213–216. doi: 10.1016/j.hemonc.2020.06.005.
  • Elmassry M, Vutthikraivit W, Abdelmalek J, et al. Warm autoimmune hemolytic anemia as a rare cause of pulmonary embolism. Chest. 2020;158(4):A2095–A2096. doi: 10.1016/j.chest.2020.08.1810.
  • Venter C, Bezuidenhout JA, Laubscher GJ, et al. Erythrocyte, platelet, serum ferritin, and P-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19. Int J Mol Sci. 2020;21(21):8234. doi: 10.3390/ijms21218234.
  • Bundy DG, Strouse JJ, Casella JF, et al. Burden of influenza-related hospitalizations among children with sickle cell disease. Pediatrics. 2010;125(2):234–243. doi: 10.1542/peds.2009-1465.
  • Mendy A, Apewokin S, Wells AA, et al. Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 patients. medRxiv. 2020. doi: 10.1101/2020.06.25.20137323.
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
  • Tao Z, Xu J, Chen W, et al. Anemia is associated with severe illness in COVID-19: a retrospective cohort study. J Med Virol. 2021;93(3):1478–1488. doi: 10.1002/jmv.26444.
  • Bergamaschi G, Borrelli de Andreis F, Aronico N, et al. Anemia in patients with COVID-19: pathogenesis and clinical significance. Clin Exp Med. 2021;21(2):247. doi: 10.1007/s10238-021-00699-8.
  • Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529–539. doi: 10.1007/s00281-017-0629-x.
  • McGonagle D, Sharif K, O’Regan A, et al. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. doi: 10.1016/j.autrev.2020.102537.
  • Telfer P, De la Fuente J, Sohal M, et al. Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients. Haematologica. 2020;105(11):2651–2654. doi: 10.3324/haematol.2020.259440.
  • Taneri PE, Gómez-Ochoa SA, Llanaj E, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35(8):763–773. doi: 10.1007/s10654-020-00678-5.
  • Faghih Dinevari M, Somi MH, Sadeghi Majd E, et al. Anemia predicts poor outcomes of COVID-19 in hospitalized patients: a prospective study in Iran. BMC Infect Dis. 2021;21(1):170. doi: 10.1186/s12879-021-05868-4.
  • Kehinde TA, Osundiji MA. Sickle cell trait and the potential risk of severe coronavirus disease 2019—a mini-review. Eur J Haematol. 2020;105(5):519–523. doi: 10.1111/ejh.13478.
  • Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: a collision of complement, coagulation and inflammatory pathways. J Thromb Haemost. 2020;18(9):2110–2117. doi: 10.1111/jth.14981.
  • Hosseini P, Fallahi MS, Erabi G, et al. Multisystem inflammatory syndrome and autoimmune diseases following COVID-19: molecular mechanisms and therapeutic opportunities. Front Mol Biosci. 2022;9:804109. doi: 10.3389/fmolb.2022.804109.
  • Sonnweber T, Boehm A, Sahanic S, et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study. Respir Res. 2020;21(1):276. doi: 10.1186/s12931-020-01546-2.
  • Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–847. doi: 10.1002/ajh.25829.
  • Santosh Kumar Sidhwani TM, Khatoon A, Shaikh F, et al. Inflammatory markers and COVID-19 disease progression. J Infect Public Health. 2023;16(9):1386–1391. doi: 10.1016/j.jiph.2023.06.018.
  • Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. doi: 10.1001/jamainternmed.2020.0994.
  • Oh SM, Skendelas JP, Macdonald E, et al. On-admission anemia predicts mortality in COVID-19 patients: A single center, retrospective cohort study. Am J Emerg Med. 2021;48:140–147. doi: 10.1016/j.ajem.2021.03.083.
  • Lanser L, Burkert FR, Bellmann-Weiler R, et al. Dynamics in anemia development and dysregulation of iron homeostasis in hospitalized patients with COVID-19. Metabolites. 2021;11(10):653. doi: 10.3390/metabo11100653.
  • Qian G-Q, Yang N-B, Ding F, et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. QJM. 2020;113(7):474–481. doi: 10.1093/qjmed/hcaa089.
  • Wu T, Kang SC, Feng W, et al. A case report of aplastic anemia accompanied with COVID-19. Zhonghua Xue Ye Xue Za Zhi. 2020;41(4):340.
  • Vogt A-CS, Arsiwala T, Mohsen M, et al. On iron metabolism and its regulation. Int J Mol Sci. 2021;22(9):4591.
  • Gómez-Pastora J, Weigand M, Kim J, et al. Hyperferritinemia in critically ill COVID-19 patients – is ferritin the product of inflammation or a pathogenic mediator? Clin Chim Acta. 2020;509:249–251. doi: 10.1016/j.cca.2020.06.033.
  • Edeas M, Saleh J, Peyssonnaux C. Iron: innocent bystander or vicious culprit in COVID-19 pathogenesis? Int J Infect Dis. 2020;97:303–305. doi: 10.1016/j.ijid.2020.05.110.
  • Zhvania M, Kvezereli-Kopadze M, Kutubidze T, et al. COVID-19 and children: complications and late outcomes. Georgian Med News. 2021;313:124–127.